•As of 1 January 2026, an important update to the Regulation (EU) 2017/745 (MDR) reinforces how manufacturers must assess hazardous substances in medical devices—especially phthalates, CMR, and endocrine-disrupting substances.This is …
Consultancy and solutions provider of risk management and compliance services to Life Sciences Industry
Consultancy and solutions provider of risk management and compliance services to Life Sciences Industry